Pain News and Research

Latest Pain News and Research

New combinations of postoperative pain treatment decreased both pain and use of pain relievers

New combinations of postoperative pain treatment decreased both pain and the use of narcotic pain relievers according to two studies presented this week at the 2013 Clinical Congress of the American College of Surgeons.

9 Oct 2013

Recent study confirms healing properties of liquorice in lung surgery patients

In Traditional Chinese Medicine (TCM), liquorice is regarded as a "panacea". A recent study by the University Department of Anaesthetics, General Intensive Care Medicine and Pain Therapy at the MedUni Vienna has now, for the first time, scientifically confirmed the healing properties of this natural substance.

9 Oct 2013

Anesthesia Business Consultants unveils newest tool, F1RSTAnalytics at ASA Annual Convention

Anesthesia Business Consultants (ABC) announces today that it will unveil its newest tool, F1RSTAnalytics™ at the ASA Annual Convention in San Francisco, CA, October 12-16th. F1RSTAnalytics offers "Insight at Your Fingertips."

9 Oct 2013

ECA Medical Instruments unveils new family of disposable Torque-Fast surgical instruments

ECA Medical Instruments, the leading designer and manufacturer of single-procedure torque-limiting and fixed-driver surgical instruments and kits for the medical industry and surgeons worldwide, unveiled its new family of disposable Torque-Fast instruments for safe and accurate securing of medical device implants.

9 Oct 2013

Survey reveals 60% of Americans report of having Silicon Valley Syndrome

LUMO BodyTech, the makers of the LUMOback smart posture and movement feedback system, today announced national survey results revealing a widespread phenomenon LUMO calls 'Silicon Valley Syndrome'.

9 Oct 2013

Senate Democrats ponder 'clean' debt limit bill; GOP holds Obamacare ground

Democratic leaders in the Senate are mulling passing a "clean" bill -- one with no other policy changes -- that would increase the nation's debt limit. House Republican leadership continues to refuse any proposal that doesn't strike some parts of the new health law. In the meantime, talk about the government shutdown sometimes ignores the health law's role in it.

9 Oct 2013

EGS announced that enrollment for RESPECT study has surpassed company's original target

EndoGastric Solutions (EGS), the leader in endoluminal reconstructive treatment for gastroesophageal reflux disease (GERD), announced today that enrollment for the RESPECT study (Randomized EsophyX vs. Sham/Placebo Controlled Trial) is complete and has surpassed the company's original target of 120 patients.

9 Oct 2013

Moximed initiates pivotal trial of KineSpring System implantation in knee osteoarthritis patients

Moximed, Inc. announced today that the KineSpring® System, an implantable medical spring for knee osteoarthritis that works by unloading the weight on the diseased joint, has been successfully implanted in the first patients enrolled in the UK arm of its multi-centre GOAL study.

9 Oct 2013

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it is advancing its Development Candidate for ALN-AS1, an RNAi therapeutic targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of hepatic porphyrias including acute intermittent porphyria (AIP).

9 Oct 2013

Acorda Therapeutics initiates second clinical trial of Glial Growth Factor 2 in heart failure patients

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the first patient has been enrolled in the second clinical trial of Glial Growth Factor 2 (GGF2). This Phase 1b single-infusion trial in people with heart failure will assess tolerability of three dose levels of GGF2, and also includes several explorative measures of efficacy.

9 Oct 2013

MNK-795 for acute pain management: an interview with Dr Lynn Webster

MNK-795 is a product in development that is intended to be used for acute pain. It has some unique properties. First, it is an extended release formulation, meaning that it’s going to last more than three to four hours. It was studied to be dosed once every 12 hours, and that is unique for an acute pain formulation.

8 Oct 2013

First Edition: October 8, 2013

Today's headlines include the latest on how the health law's online insurance marketplaces are operating and what caused the initial systemic problems.

8 Oct 2013

Viewpoints: U.S. 'designed for stalemate'; tea party's last stand?; 'war over Obamacare' not over

Though the big social insurance programs are still running, many federal programs that directly target those in the most need are either empty or running on fumes. ... The growth of the modern state is tied to the awareness of public issues in health and the need to address them.

8 Oct 2013

Research: Triathletes feel less pain than casual exercisers

Triathletes participate in a grueling endurance sport, swimming, bicycling, and running long distances without rest. In training and competitions, they regularly push their bodies beyond the limits most of us can endure. But while there is no doubt that triathletes are tough, very little is known about what gives them their exceptional abilities.

8 Oct 2013

Tel Aviv University researchers find chemicals in marijuana could help treat MS

Multiple sclerosis is an inflammatory disease in which the immune system attacks the nervous system. The result can be a wide range of debilitating motor, physical, and mental problems. No one knows why people get the disease or how to treat it.

8 Oct 2013

Work becomes matter of life and death to person suffering from stress

Stress causes today more cases of prolonged absence from work due to sickness. Work and identity are more closely knit together than ever before, and therefore work becomes a matter of life and death to the person suffering from stress.

7 Oct 2013

Osteoarthritis and exercise: an interview with Dr Nicola Walsh, Associate Professor at the University of the West of England

Exercise helps to keep the surrounding muscles strong to protect the joint, and also reduces stiffness that people frequently experience in the morning or after periods of inactivity. Joints are meant to move, so keeping them mobile will assist with joint health, maintain range of movement and enhance stability.

7 Oct 2013

Newly discovered compound could be developed as antifungal drug to treat fungal infections

On a molecular level, you have more in common with shower curtain mold or the mushrooms on your pizza than you might think. Humans and fungi share similar proteins, a biological bond that makes curing fungal infections difficult and expensive.

7 Oct 2013

AbbVie announces HUMIRA phase II study results for treating hidradenitis suppurativa

AbbVie (NYSE: ABBV) today announced results from a post-hoc analysis of an investigational Phase II study, which evaluated HUMIRA® (adalimumab) in the treatment of patients with moderate-to-severe hidradenitis suppurativa (HS) after 16 weeks of therapy.

7 Oct 2013

New study highlights that physicians prefer topical therapies for actinic keratosis

Over 90 per cent of physicians treating actinic keratosis (AK) prefer short duration treatment options with fast resolving local skin responses (LSRs), is the finding of a global study (‘Physician Perceptions and Experience of Current Treatment in Actinic Keratosis’) that is being presented today at the 22nd Congress of the European Academy of Dermatology and Venereology (EADV).

5 Oct 2013

Pain News and Research

Latest Pain News and Research

New combinations of postoperative pain treatment decreased both pain and use of pain relievers

Recent study confirms healing properties of liquorice in lung surgery patients

Anesthesia Business Consultants unveils newest tool, F1RSTAnalytics at ASA Annual Convention

ECA Medical Instruments unveils new family of disposable Torque-Fast surgical instruments

Survey reveals 60% of Americans report of having Silicon Valley Syndrome

Senate Democrats ponder 'clean' debt limit bill; GOP holds Obamacare ground

EGS announced that enrollment for RESPECT study has surpassed company's original target

Moximed initiates pivotal trial of KineSpring System implantation in knee osteoarthritis patients

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Acorda Therapeutics initiates second clinical trial of Glial Growth Factor 2 in heart failure patients

MNK-795 for acute pain management: an interview with Dr Lynn Webster

First Edition: October 8, 2013

Viewpoints: U.S. 'designed for stalemate'; tea party's last stand?; 'war over Obamacare' not over

Research: Triathletes feel less pain than casual exercisers

Tel Aviv University researchers find chemicals in marijuana could help treat MS

Work becomes matter of life and death to person suffering from stress

Osteoarthritis and exercise: an interview with Dr Nicola Walsh, Associate Professor at the University of the West of England

Newly discovered compound could be developed as antifungal drug to treat fungal infections

AbbVie announces HUMIRA phase II study results for treating hidradenitis suppurativa

New study highlights that physicians prefer topical therapies for actinic keratosis

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Pain News and Research

Latest Pain News and Research

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Newsletters you may be interested in